Securities code: 603168 securities abbreviation: Zhejiang Shapuaisi Pharmaceutical Co.Ltd(603168) Announcement No.: pro 2022-007 Zhejiang Shapuaisi Pharmaceutical Co.Ltd(603168)
Announcement on progress of entrusted financial management
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
Redemption of financial products upon maturity: Industrial Bank Co.Ltd(601166) Jiaxing Pinghu sub branch (hereinafter referred to as ” Industrial Bank Co.Ltd(601166) “) xingyin financial snowball poly phase III net worth financial products in 2021, with a principal of 50 million yuan and a maturity income of 661500 yuan.
Redemption of financial products without fixed term: China Minsheng Banking Corp.Ltd(600016) (hereinafter referred to as ” China Minsheng Banking Corp.Ltd(600016) “) Minsheng daily increases profits on public financial products, with a principal of 50 million yuan. Zhejiang Shapuaisi Pharmaceutical Co.Ltd(603168) (hereinafter referred to as “the company”) held the 20th meeting of the Fourth Board of directors on April 16, 2021 to consider and adopt the proposal on using idle self owned funds for entrusted financial management: the company decided to use idle self owned funds of no more than 500 million yuan (accounting for 38.28% of the company’s audited net assets on December 31, 2020) for entrusted financial management for low-risk investment Short term bank financial products and brokerage financial products are valid for one year from April 16, 2021. Within the above quota and period, the funds can be used on a rolling basis. For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) on April 20, 2021 Announcement of disclosure (Announcement No.: pro 2021-020, 022).
1、 Redemption of financial products purchased with some idle self owned funds
The company purchased China Minsheng Banking Corp.Ltd(600016) 150 million yuan financial products and Industrial Bank Co.Ltd(601166) 50 million yuan financial products with idle self owned funds on September 17, 2020 and September 13, 2021 respectively. For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) on September 19, 2020 and September 14, 2021 Announcement of disclosure (Announcement No.: pro 2020-055, 2021-056). The company has redeemed China Minsheng Banking Corp.Ltd(600016) 100 million yuan of financial products. Please refer to the website of Shanghai Stock Exchange on September 1, 2021 and September 28, 2021 (www.sse. Com. CN.) Announcement of disclosure (Announcement No.: pro 2021-054, 2021-057). As of the date of this announcement, all financial products have been redeemed. The details of this redemption are as follows:
be entrusted
Subscription amount actual annualized return to maturity of this redemption fund product type product name product term return type
(10000 yuan) amount (10000 yuan) (10000 yuan) rate of return
Minsheng Bank‘s financial management Minsheng daily increases profits to the public and non breakeven floating
15000 no fixed term 5000 444.63/
Bank products and financial products [note] dynamic income type
Xingyin financial management golden snowball gathering
Industrial Bank financial management non breakeven floating
Profit in the third phase of 2021 net 5000 119 days 5000 66.15 4.00% of bank products movable income type
Value based financial products
Note: when the company partially redeems the shares of this financial product, the bank will pay the redeemed shares to the company after confirming the success of the redemption
The remaining shares of financial products will be automatically renewed for investment according to the corresponding financial amount. As of the date of this announcement, Minsheng has increased profits every day
All public financial products have been redeemed, and the due income is all the income of the subscription amount of 150 million yuan.
2、 As of the date of this announcement, the company has used its own funds for entrusted financial management in the last 12 months
Amount: 10000 yuan
The number has not been recovered, the actual investment amount of financial product type, the actual principal and the actual income have been recovered
Gold amount
1 bank financial products 35000 860.63 million
Total 35000 860.63 0000
The maximum amount invested in a single day in the last 12 months is 35000
Maximum investment amount in a single day in the last 12 months / net assets of the last year (%) 26.80
Cumulative income from entrusted financial management in the last 12 months / net profit of the last year (%) 4.80
Currently used financial limit 0
Unused financial limit 50000
Total financial limit: 50000
Note: “actual income” refers to the accumulated income from entrusted financial management received in the last 12 months, and VAT is not deducted.
“Recently
The value of “cumulative income from entrusted financial management in 12 months / net profit of the latest year” is the absolute value.
The maximum daily investment amount of the company’s entrusted financial management with its own funds in the last 12 months is 3.50
RMB100mn As of the date of this announcement, the amount (principal) of entrusted financial management by the company is RMB 0 (including this time);
It does not exceed the investment quota approved by the board of directors of the company for using idle self owned funds of no more than 500 million yuan to invest in low-risk short-term bank financial products and brokerage property products (within the above quota, the funds can be used on a rolling basis).
It is hereby announced.
Zhejiang Shapuaisi Pharmaceutical Co.Ltd(603168) board of directors January 12, 2022
